首页 | 本学科首页   官方微博 | 高级检索  
检索        

miR-375调控PDGFC基因表达抑制肝癌血管生成
引用本文:王涛,李东,彭晶晶,刘煜,孙非凡,王丹,程朋,苏晓妹,张伶,高辉,原薇薇,李华,张涛.miR-375调控PDGFC基因表达抑制肝癌血管生成[J].中国肿瘤临床,2017,44(20):1007-1013.
作者姓名:王涛  李东  彭晶晶  刘煜  孙非凡  王丹  程朋  苏晓妹  张伶  高辉  原薇薇  李华  张涛
作者单位:中国人民解放军成都军区总医院肿瘤诊治中心(成都市 610083)
基金项目:本文课题受四川省科技厅重点研发项目(2017SZ0066),四川省科技厅科技支撑计划项目(2015FZ0073),四川省卫计委科研课题(16PJ026),四川省中医药管理局青年中医药科研课题(2014K057),成都军区总医院研究型人才经费资助 This work was supported by the Scientific Research Foundation of the Science and Technology Department of Sichuan Province(2015FZ0073 and 2017SZ0066),the Scientific Research Project of the Health Department of Sichuan Province(16PJ026),the Sci-entific Research Project of the Administration of Traditional Chinese Medicine of Sichuan Province(2014K057)
摘    要:  目的  miR-375已被证明能够抑制肝癌细胞增殖、迁移和侵袭,促进肝癌细胞凋亡,本研究旨在探索miR-375对肝癌新生血管生成的影响及其分子机制。  方法  利用血管生成相关的功能实验探索miR-375对肝癌新生血管生成的影响;使用生物信息学方法预测miR-375潜在的与血管生成相关的功能靶基因;在肝癌细胞系中过表达和下调表达miR-375,验证miR-375对靶基因的调控作用,并利用双荧光素酶报告实验明确其分子机制;靶基因功能挽救实验明确miR-375通过调控靶基因的表达发挥抑制肝癌新生血管生成的作用。  结果  miR-375能够抑制肝癌新生血管生成;血小板源性生长因子C(PDGFC)是miR-375的潜在功能靶基因;miR-375能够直接作用于PDGFC基因mRNA 3'-非编码端(3'-UTR)而抑制PDGFC基因表达;miR-375能够通过抑制PDGFC基因表达抑制肝癌新生血管生成。  结论  miR-375能够调控PDGFC基因表达抑制肝癌新生血管生成。 

关 键 词:原发性肝细胞癌    miR-375    血管生成    PDGFC
收稿时间:2017-06-20

MiR-375 suppresses angiogenesis of hepatocellular carcinoma by targeting platelet-de-rived growth factor-C
Tao WANG,Dong LI,Jingjing PENG,Yu LIU,Feifan SUN,Dan WANG,Peng CHENG,Xiaomei SU,Lin ZHANG,Hui GAO,Weiwei YUAN,Hua LI,Tao ZHANG.MiR-375 suppresses angiogenesis of hepatocellular carcinoma by targeting platelet-de-rived growth factor-C[J].Chinese Journal of Clinical Oncology,2017,44(20):1007-1013.
Authors:Tao WANG  Dong LI  Jingjing PENG  Yu LIU  Feifan SUN  Dan WANG  Peng CHENG  Xiaomei SU  Lin ZHANG  Hui GAO  Weiwei YUAN  Hua LI  Tao ZHANG
Institution:Department of Oncology, Chengdu Military General Hospital, Chengdu 610083, China
Abstract:Objective:Abnormal angiogenesis is an important hallmark of HCC. Ectopic miR-375 overexpression led to repression of proliferation, migration, invasion, and colony formation, and it induced apoptosis in hepatoma cells as well. In this study, we explored the effect of miR-375 on HCC angiogenesis. Methods:We evaluated the antiangiogenic effects of miR-375 using human umbilical vein endothelial cells, tube formation assays, rat aortic ring sprouting assays, and chicken chorioallantoic membrane assays. Bioinformatics software was used to predict the downstream target gene of miR-375. MiR-375 regulation to target genes was explored by overexpres-sion and knockdown of miR-375 in hepatoma cells. Luciferase assay was performed to confirm its molecular mechanism. Rescue assay of target gene was further used to prove that miR-375 inhibited HCC angiogenesis by directly regulating its target gene. Results:MiR-375 inhibited HCC angiogenesis. Platelet-derived growth factor-C (PDGFC) was a potential target gene of miR-375. MiR-375 inhibited PDGFC expression in hepatoma cells by targeting its 3′-UTR. MiR-375 exerted its antiangiogenic effect partially by PDGFC inhibition. Conclusion:MiR-375 repressed tumor angiogenesis by targeting PDGFC in HCC.
Keywords:primary hepatocellular carcinoma  miR-375  angiogenesis  PDGFC
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号